ČIČÁTKOVÁ, Petra and Daniela ŽÁČKOVÁ. Cílená terapie u chronické myeloidní leukemie (Targeted therapy in chronic myeloid leukaemia). Acta medicinae. Brno: ERA média, s.r.o., 2023, vol. 2023, 12-13, p. 106-110. ISSN 1805-398X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cílená terapie u chronické myeloidní leukemie
Name (in English) Targeted therapy in chronic myeloid leukaemia
Authors ČIČÁTKOVÁ, Petra (203 Czech Republic, belonging to the institution) and Daniela ŽÁČKOVÁ (203 Czech Republic, belonging to the institution).
Edition Acta medicinae, Brno, ERA média, s.r.o. 2023, 1805-398X.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/23:00133924
Organization unit Faculty of Medicine
Keywords (in Czech) chronická myeloidní leukemie; inhibotory tyrosinkináz; asciminib; remise bez nutnosti terapie
Keywords in English chronic myeloid leukemia; tyrosine kinase inhibitors; asciminib; remission without the need for therapy
Tags rivok
Tags Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 3/4/2024 13:31.
Abstract
Článek nabízí pohled na aktuální cílenou léčbu chronické myelodiní leukemie i v kontextu jejího vysazení a následné remise bez nutnosti terapie.
Abstract (in English)
The article offers an insight into the current targeted treatment of chronic myelodine leukemia in the context of its discontinuation and subsequent remission without the need for therapy.
Links
MUNI/A/1224/2022, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X
Investor: Masaryk University
PrintDisplayed: 10/7/2024 20:38